These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9135031)

  • 1. Quantitative structure-activity relationships among macrolide antibacterial agents: in vitro and in vivo potency against Pasteurella multocida.
    McFarland JW; Berger CM; Froshauer SA; Hayashi SF; Hecker SJ; Jaynes BH; Jefson MR; Kamicker BJ; Lipinski CA; Lundy KM; Reese CP; Vu CB
    J Med Chem; 1997 Apr; 40(9):1340-6. PubMed ID: 9135031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repromicin derivatives with potent antibacterial activity against Pasteurella multocida.
    McFarland JW; Hecker SJ; Jaynes BH; Jefson MR; Lundy KM; Vu CB; Glazer EA; Froshauer SA; Hayashi SF; Kamicker BJ; Reese CP; Olson JA
    J Med Chem; 1997 Mar; 40(6):1041-5. PubMed ID: 9083494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro activity of 12 antibiotics used in veterinary medicine against Mannheimia haemolytica and Pasteurella multocida isolated from calves in the Netherlands].
    Mevius DJ; Hartman EG
    Tijdschr Diergeneeskd; 2000 Mar; 125(5):147-52. PubMed ID: 10730339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic/pharmacodynamic integration of cefquinome against Pasteurella Multocida in a piglet tissue cage model.
    Zhang L; Wu X; Huang Z; Kang Z; Chen Y; Shen X; Cai Q; Ding H
    J Vet Pharmacol Ther; 2019 Jan; 42(1):60-66. PubMed ID: 30407642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics/pharmacodynamics of marbofloxacin in a Pasteurella multocida serious murine lung infection model.
    Qu Y; Qiu Z; Cao C; Lu Y; Sun M; Liang C; Zeng Z
    BMC Vet Res; 2015 Dec; 11():294. PubMed ID: 26631082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new pleuromutilin candidate with potent antibacterial activity against Pasteurella multocida.
    Fu Y; Ma L; Yi Y; Fan Y; Liang J; Shang R
    Microb Pathog; 2019 Feb; 127():202-207. PubMed ID: 30529392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural modification of sanguinarine and chelerythrine and their antibacterial activity.
    Miao F; Yang XJ; Zhou L; Hu HJ; Zheng F; Ding XD; Sun DM; Zhou CD; Sun W
    Nat Prod Res; 2011 May; 25(9):863-75. PubMed ID: 21491327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues.
    Griesgraber G; Kramer MJ; Elliott RL; Nilius AM; Ewing PJ; Raney PM; Bui MH; Flamm RK; Chu DT; Plattner JJ; Or YS
    J Med Chem; 1998 May; 41(10):1660-70. PubMed ID: 9572891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of spectinomycin and comparator agents against Pasteurella multocida and Mannheimia haemolytica from respiratory tract infections of cattle.
    Schwarz S; Kehrenberg C; Salmon SA; Watts JL
    J Antimicrob Chemother; 2004 Feb; 53(2):379-82. PubMed ID: 14729757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of tulathromycin and ceftiofur combined with other antimicrobial agents using bovine Pasteurella multocida and Mannheimia haemolytica isolates.
    Sweeney MT; Brumbaugh GW; Watts JL
    Vet Ther; 2008; 9(3):212-22. PubMed ID: 19003782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant prevention concentration and PK-PD relationships of enrofloxacin for Pasteurella multocida in buffalo calves.
    Balaje RM; Sidhu PK; Kaur G; Rampal S
    Res Vet Sci; 2013 Dec; 95(3):1114-24. PubMed ID: 23941961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resistance of bovine and porcine Pasteurella to florfenicol and other antibiotics].
    Hörmansdorfer S; Bauer J
    Berl Munch Tierarztl Wochenschr; 1998; 111(11-12):422-6. PubMed ID: 9880937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between immobilized artificial membrane (IAM) HPLC data and lipophilicity in n-octanol for quinolone antibacterial agents.
    Barbato F; Cirocco V; Grumetto L; Immacolata La Rotonda M
    Eur J Pharm Sci; 2007 Aug; 31(5):288-97. PubMed ID: 17540545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pH on the in vitro activity of and propensity for emergence of resistance to fluoroquinolones, macrolides, and a ketolide.
    Dalhoff A; Schubert S; Ullmann U
    Infection; 2005 Dec; 33 Suppl 2():36-43. PubMed ID: 16518710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antimicrobial evaluation of new 2-substituted 5,7-di-tert-butylbenzoxazoles.
    Vinsova J; Cermakova K; Tomeckova A; Ceckova M; Jampilek J; Cermak P; Kunes J; Dolezal M; Staud F
    Bioorg Med Chem; 2006 Sep; 14(17):5850-65. PubMed ID: 16784871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pasteurella multocida pneumonia].
    Miyashita T
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):384-6. PubMed ID: 10088422
    [No Abstract]   [Full Text] [Related]  

  • 18. A Chronic Respiratory Pasteurella multocida Infection Is Well-Controlled by Long-Term Macrolide Therapy.
    Seki M; Sakata T; Toyokawa M; Nishi I; Tomono K
    Intern Med; 2016; 55(3):307-10. PubMed ID: 26831030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postantibiotic effects and postantibiotic sub-MIC effects of erythromycin, roxithromycin, tilmicosin, and tylosin on Pasteurella multocida.
    Lim J; Yun H
    Int J Antimicrob Agents; 2001 Jun; 17(6):471-6. PubMed ID: 11397617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of Pasteurella multocida meningitis with aztreonam.
    Jordan EF; Nye MB; Luque AE
    Scand J Infect Dis; 2007; 39(1):72-4. PubMed ID: 17366017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.